Profilo
Nancy Sacco is a former Head of Clinical Development at AnaptysBio, Inc. and a former Vice President and Head of Clinical Development at Xentria, Inc. She also served as the Chief Development Officer at Hexima Ltd.
in 2021-2022.
Sacco holds a doctorate degree from West Virginia University School of Medicine.
Precedenti posizioni note di Nancy Sacco
Società | Posizione | Fine |
---|---|---|
HEXIMA LIMITED | Corporate Officer/Principal | 15/10/2022 |
Xentria, Inc.
Xentria, Inc. BiotechnologyHealth Technology Xentria, Inc. is a biopharmaceutical company founded in 2020 that specializes in creating collaborations and partnerships to advance drug development. The company is based in Chicago, IL. The company is dedicated to delivering customized approaches to drug innovation through patient engagement and effective partnerships. Xentria is focused on becoming a critical leader in the biopharma industry through a strong portfolio of biologic products for patients. | Chief Tech/Sci/R&D Officer | - |
ANAPTYSBIO, INC. | Chief Tech/Sci/R&D Officer | - |
Formazione di Nancy Sacco
West Virginia University School of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 2 |
---|---|
ANAPTYSBIO, INC. | Health Technology |
HEXIMA LIMITED | Health Technology |
Aziende private | 1 |
---|---|
Xentria, Inc.
Xentria, Inc. BiotechnologyHealth Technology Xentria, Inc. is a biopharmaceutical company founded in 2020 that specializes in creating collaborations and partnerships to advance drug development. The company is based in Chicago, IL. The company is dedicated to delivering customized approaches to drug innovation through patient engagement and effective partnerships. Xentria is focused on becoming a critical leader in the biopharma industry through a strong portfolio of biologic products for patients. | Health Technology |
- Borsa valori
- Insiders
- Nancy Sacco